Statistics

Total Visits

Views
Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by64

Select a period of time:

Number of views in the range

Views
Cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel (D): Analysis by28

Views

Views
September 20252
October 20250
November 20254
December 20255
January 20266
February 20261
March 202610
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
Brazil5
Argentina4
Peru2
Canada1
Germany1
Finland1
United Kingdom1
South Korea1
Singapore1
 

Top cities views

Views
Ashburn3
San Jose2
São Paulo2
Lima2
Apex1
Bauru1
Delmiro Gouveia1
Frankfurt am Main1
Fresno1
Helsinki1